Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 3
Original Articles
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry
Rena Bucksteina Division of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada;b Department of Medicine, University of Toronto, Toronto, CanadaCorrespondence[email protected]
https://orcid.org/0000-0001-9520-7386View further author information
https://orcid.org/0000-0001-9520-7386View further author information, , Karen W.L. Yeeb Department of Medicine, University of Toronto, Toronto, Canada;c Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network, Toronto, Canadahttps://orcid.org/0000-0002-2572-9952View further author information
https://orcid.org/0000-0002-2572-9952View further author information, Michelle Geddesd Department of Medicine, Tom Baker Cancer Centre, Calgary, Canadahttps://orcid.org/0000-0003-1662-6000View further author information
https://orcid.org/0000-0003-1662-6000View further author information, Heather A. Leitche Division of Hematology, St. Paul’s Hospital, University of British Columbia, Vancouver, Canadahttps://orcid.org/0000-0002-7899-2025View further author information
https://orcid.org/0000-0002-7899-2025View further author information, Grace Christouf Clinical epidemiology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canadahttps://orcid.org/0000-0003-0453-8046View further author information
https://orcid.org/0000-0003-0453-8046View further author information, Versha Banerjig CancerCare Manitoba Foundation, Winnipeg, Canadahttps://orcid.org/0000-0002-7415-8818View further author information
https://orcid.org/0000-0002-7415-8818View further author information, , , , , Thomas Nevillj Division of Hematology, Leukemia/Bone Marrow Transplant Program of BC, BC Cancer, University of British Columbia, Vancouver, Canadahttps://orcid.org/0000-0002-3124-541XView further author information
https://orcid.org/0000-0002-3124-541XView further author information, , , Anne Parmentiera Division of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canadahttps://orcid.org/0000-0001-5695-9622View further author information
https://orcid.org/0000-0001-5695-9622View further author information, , , , Chris Camerono Value and Evidence Division, Marketing and Market Access, EVERSANA™, Sydney, Canadahttps://orcid.org/0000-0003-3613-760XView further author information
https://orcid.org/0000-0003-3613-760XView further author information & Paul Spino Value and Evidence Division, Marketing and Market Access, EVERSANA™, Sydney, Canadahttps://orcid.org/0000-0002-4622-3547View further author information
https://orcid.org/0000-0002-4622-3547View further author information show all